Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 May;53(5):1284–1289. doi: 10.1172/JCI107675

Effects of Alterations of Plasma Free Fatty Acid Levels on Pancreatic Glucagon Secretion in Man

John E Gerich 1, Maurice Langlois 1, Victor Schneider 1, John H Karam 1, Claudio Noacco 1
PMCID: PMC302615  PMID: 4825225

Abstract

The present investigation was undertaken to ascertain whether alterations in plasma free fatty acids (FFA) affect pancreatic glucagon secretion in man since FFA have been reported to influence pancreatic alpha cell function in other species. Elevation of plasma FFA from a mean (±SE) basal level of 0.478±0.036 mM to 0.712±0.055 mM after heparin administration caused plasma glucagon levels to fall approximately 50%, from a basal value of 122±15 pg/ml to 59±14 pg/ml (P < 0.001). Lowering of plasma FFA from a basal level of 0.520±0.046 mM to 0.252±0.041 mM after nicotinic acid administration raised plasma glucagon from a basal level of 113±18 pg/ml to 168±12 pg/ml (P < 0.005). Infusion of glucose elevated plasma glucose levels to the same degree that heparin raised plasma FFA levels. This resulted in suppression of plasma glucagon despite the fact that plasma FFA levels also were suppressed. Glucagon responses to arginine were diminished after elevation of plasma FFA (P < 0.01) and during infusion of glucose (P < 0.01). Diminution of plasma FFA by nicotinic acid did not augment glucagon responses to arginine.

These results thus demonstrate that rather small alterations in plasma FFA within the physiologic range have a significant effect on glucagon secretion in man. Although the effects of glucose appear to predominate over those of FFA, alterations in plasma FFA may nevertheless exert an important physiologic influence over human pancreatic alpha cell function, especially in the postabsorptive state.

Full text

PDF
1284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguilar-Parada E., Eisentraut A. M., Unger R. H. Effects of starvation on plasma pancreatic glucagon in normal man. Diabetes. 1969 Nov;18(11):717–723. doi: 10.2337/diab.18.11.717. [DOI] [PubMed] [Google Scholar]
  2. Balasse E. O., Ooms H. A. Role of plasma free fatty acids in the control of insulin secretion in man. Diabetologia. 1973 Apr;9(2):145–151. doi: 10.1007/BF01230695. [DOI] [PubMed] [Google Scholar]
  3. Edwards J. C., Hellerström C., Petersson B., Taylor K. W. Oxidation of glucose and fatty acids in normal and in A 2 -cell rich pancreatic islets isolated from guinea-pigs. Diabetologia. 1972 Apr;8(2):93–98. doi: 10.1007/BF01235632. [DOI] [PubMed] [Google Scholar]
  4. Edwards J. C., Howell S. L., Taylor K. W. Fatty acids as regulators of glucagon secretion. Nature. 1969 Nov 22;224(5221):808–809. doi: 10.1038/224808a0. [DOI] [PubMed] [Google Scholar]
  5. Edwards J. C., Taylor K. W. Fatty acids and the release of glucagon from isolated guinea-pig islets of Langerhans incubated in vitro. Biochim Biophys Acta. 1970 Aug 14;215(2):310–315. doi: 10.1016/0304-4165(70)90029-2. [DOI] [PubMed] [Google Scholar]
  6. Ensinck J. W., Shepard C., Dudl R. J., Williams R. H. Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma. J Clin Endocrinol Metab. 1972 Sep;35(3):463–467. doi: 10.1210/jcem-35-3-463. [DOI] [PubMed] [Google Scholar]
  7. GRODSKY G. M., FORSHAM P. H. An immunochemical assay of total extractable insulin in man. J Clin Invest. 1960 Jul;39:1070–1079. doi: 10.1172/JCI104122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gerich J. E., Karam J. H., Forsham P. H. Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab. 1973 Sep;37(3):479–481. doi: 10.1210/jcem-37-3-479. [DOI] [PubMed] [Google Scholar]
  9. Laurell S., Tibbling G. Colorimetric micro-determination of free fatty acids in plasma. Clin Chim Acta. 1967 Apr;16(1):57–62. doi: 10.1016/0009-8981(67)90269-0. [DOI] [PubMed] [Google Scholar]
  10. Lefebvre P. The physiological effect of glucagon on fat-mobilisation. Diabetologia. 1966 Sep;2(2):130–132. doi: 10.1007/BF00423023. [DOI] [PubMed] [Google Scholar]
  11. Levin S. R., Karam J. H., Hane S., Grodsky G. M., Forsham P. H. Enhancement of arginine-induced insulin secretion in man by prior administration of glucose. Diabetes. 1971 Mar;20(3):171–176. doi: 10.2337/diab.20.3.171. [DOI] [PubMed] [Google Scholar]
  12. Luyckx A. S., Lefebvre P. J. Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med. 1970 Feb;133(2):524–528. doi: 10.3181/00379727-133-34511. [DOI] [PubMed] [Google Scholar]
  13. Madison L. L., Seyffert W. A., Jr, Unger R. H., Barker B. Effect on plasma free fatty acids on plasma glucagon and serum insulin concentrations. Metabolism. 1968 Apr;17(4):301–304. doi: 10.1016/0026-0495(68)90097-8. [DOI] [PubMed] [Google Scholar]
  14. Müller W. A., Faloona G. R., Unger R. H. Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med. 1973 Jan;54(1):52–57. doi: 10.1016/0002-9343(73)90083-1. [DOI] [PubMed] [Google Scholar]
  15. Ruderman N. B., Toews C. J., Shafrir E. Role of free fatty acids in glucose homeostasis. Arch Intern Med. 1969 Mar;123(3):299–313. [PubMed] [Google Scholar]
  16. Unger R. H. Glucagon physiology and pathophysiology. N Engl J Med. 1971 Aug 19;285(8):443–449. doi: 10.1056/NEJM197108192850806. [DOI] [PubMed] [Google Scholar]
  17. Unger R. H., Ohneda A., Aguilar-Parada E., Eisentraut A. M. The role of aminogenic glucagon secretion in blood glucose homeostasis. J Clin Invest. 1969 May;48(5):810–822. doi: 10.1172/JCI106039. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES